LONDON, Nov 5 (Reuters) - Novo Nordisk said on Wednesday it has accepted the U.S. Inflation Reduction Act (IRA)'s maximum fair price for its diabetes and obesity medicines Ozempic, Wegovy and Rybelsus, which will become effective in January 2027. Novo made the disclosure in its quarterly earnings report. The price negotiation process was established under President Biden's signature IRA in...

03:49 AM EST, 11/05/2025 (MT Newswires) -- Ultragenyx Pharmaceutical ( RARE ) reported a Q3 net loss late Tuesday of $1.81 per diluted share, widening from a loss of $1.40 a year earlier. Analysts polled by FactSet expected a loss of $1.23. Revenue for the quarter ended Sept. 30 was $159.9 million, up from $139.5 million a year earlier. Analysts...

03:48 AM EST, 11/05/2025 (MT Newswires) -- Charles Collier, President, Roku Media, on October 31, 2025, sold 133,492 shares in Roku ( ROKU ) for $15,193,083. Following the Form 4 filing with the SEC, Collier has control over a total of 800 Class A common shares of the company, with 200 shares held directly and 600 controlled indirectly. SEC Filing:...

03:50 AM EST, 11/05/2025 (MT Newswires) -- Chad Michael Whalen, Executive Vice President, Worldwide Sales, on November 01, 2025, sold 9,436 shares in F5 (FFIV) for $2,356,829. Following the Form 4 filing with the SEC, Whalen has control over a total of 25,641 common shares of the company, with 25,641 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1048695/000174664025000007/xslF345X05/wk-form4_1762302508.xml ...